Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC

Description

The purpose of this study is to compare Pellograft to standard of care modalities in treating diabetic foot ulcers in human subjects, and to compare Sanograft to standard of care in treating venous leg ulcers. The study will demonstrate wound healing outcomes with comparators including time to wound epithelialization, decrease in wound size, and total number of study product applications towards healing outcome. This information is important to the Centers for Medicare and Medicaid Services (CMS) and other payors in determining coverage policy and reimbursement for this product category.

Conditions

Diabetic Foot Ulcer, Venous Leg Ulcer

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to compare Pellograft to standard of care modalities in treating diabetic foot ulcers in human subjects, and to compare Sanograft to standard of care in treating venous leg ulcers. The study will demonstrate wound healing outcomes with comparators including time to wound epithelialization, decrease in wound size, and total number of study product applications towards healing outcome. This information is important to the Centers for Medicare and Medicaid Services (CMS) and other payors in determining coverage policy and reimbursement for this product category.

A Randomized Post-Market Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating Diabetic Foot Ulcers (DFU) and SanoGraft® in Treating Venous Leg Ulcers (VLU) to SOC Treatment

Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC

Condition
Diabetic Foot Ulcer
Intervention / Treatment

-

Contacts and Locations

Vista

ILD Research, Vista, California, United States, 92801

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Subject is at least 18 years of age
  • 2. Subject has diagnosed Type 1 or Type 2 diabetes
  • 3. Subject's wound is located on foot or ankle (DFU) or leg (VLU)
  • 4. Subject has diabetic foot ulcer \> 1.0 cm2 and ≤ 25 cm2 OR venous leg ulcer \> 1.0 cm2 and ≤ 50 cm2
  • 5. Subject has adequate circulation to affected extremity with TcPO2 results of ≥ 40 mm Hg on the dorsum of the affected foot or ABI results ≥ 0.7 and≤ 1.2 or Great Toe Pressure ≥ 50 mmHg
  • 6. Subject is willing and able to comply with all protocol requirements
  • 7. Subject is willing and able to provide informed consent or obtain consent from legal authorized representative (LAR)
  • 1. Subject is pregnant
  • 2. Subject has HbA1C \> 12 within 3 months Prior to randomization
  • 3. Subject has \> 30% reduction in wound size after 2-week run-in period
  • 4. Subject has active infection, undrained abscess, or critical colonization of the wound with bacteria
  • 5. Subject has osteomyelitis or exposed bones, probes to bone or joint capsule on investigator's exam or radiographic evidence or bone culture, histology, x-ray changes or MRI
  • 6. Subject is on parenteral corticosteroids or any cytotoxic agents for 7 consecutive days during 30 days before screening. Chronic oral steroid use is not excluded if dose \< 10 mg per day of prednisone
  • 7. Subject is currently undergoing cancer treatment
  • 8. Subject has used biologic skin substitutes within 14 days of enrollment
  • 9. Subject has an allergy to suture material
  • 10. Subject has life expectancy less than six-months as assessed by the investigator
  • 11. Subject is participating in another clinical research study prior to this study completion

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Surgenex,

Study Record Dates

2025-08-02